{'52WeekChange': 'Infinity',
 'SandP52WeekChange': None,
 'address1': '202 Carnegie Center',
 'address2': 'Suite 109',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 24.64,
 'askSize': 1000,
 'averageDailyVolume10Day': 54625,
 'averageVolume': 142838,
 'averageVolume10days': 54625,
 'beta': None,
 'beta3Year': None,
 'bid': 24.49,
 'bidSize': 800,
 'bookValue': -43.65,
 'category': None,
 'circulatingSupply': None,
 'city': 'Princeton',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 25.01,
 'dayLow': 23.6701,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': None,
 'enterpriseToRevenue': None,
 'enterpriseValue': 395938496,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 27.868856,
 'fiftyTwoWeekHigh': 41.37,
 'fiftyTwoWeekLow': 13.26,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 7578316,
 'forwardEps': -3.15,
 'forwardPE': -7.774603,
 'fromCurrency': None,
 'fullTimeEmployees': 30,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.23518999,
 'heldPercentInstitutions': 0.88075995,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/oysterpointrx.com',
 'longBusinessSummary': 'Oyster Point Pharma, Inc., a clinical-stage '
                        'biopharmaceutical company, focuses on the discovery, '
                        'development, and commercialization of pharmaceutical '
                        'therapies to treat ocular surface diseases in the '
                        "United States. The company's lead product candidate "
                        'is OC-01, a nicotinic acetylcholine receptor agonist '
                        'that is in Phase III clinical trials for the '
                        'treatment of signs and symptoms of dry eye disease. '
                        'It is also developing OC-01 for neurotrophic '
                        'keratitis. Oyster Point Pharma, Inc. was founded in '
                        '2015 and is headquartered in Princeton, New Jersey.',
 'longName': 'Oyster Point Pharma, Inc.',
 'market': 'us_market',
 'marketCap': 629206848,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_541596858',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -58470000,
 'nextFiscalYearEnd': 1640908800,
 'open': 23.76,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '609 382 9032',
 'previousClose': 24.07,
 'priceHint': 2,
 'priceToBook': None,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 25.01,
 'regularMarketDayLow': 23.6701,
 'regularMarketOpen': 23.76,
 'regularMarketPreviousClose': 24.07,
 'regularMarketPrice': 23.76,
 'regularMarketVolume': 66696,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 25692400,
 'sharesPercentSharesOut': 0.0251,
 'sharesShort': 644230,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 393727,
 'shortName': 'Oyster Point Pharma, Inc.',
 'shortPercentOfFloat': 0.0783,
 'shortRatio': 5.23,
 'startDate': None,
 'state': 'NJ',
 'strikePrice': None,
 'symbol': 'OYST',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -21.217,
 'twoHundredDayAverage': 30.707481,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'cb386cd5-7003-3f47-9389-4eedf8e89543',
 'volume': 66696,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.oysterpointrx.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '08540'}